---
$id: https://graph.org.ai/products/commodity/51162613
$type: Product
source: UNSPSC
code: "51162613"
title: "Butamirate citrate"
class: "51162600"
classTitle: "Antitussives and associated cough remedies"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Butamirate citrate

**UNSPSC Code**: 51162613
**Class**: [Antitussives and associated cough remedies](Antitussives and associated cough remedies.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antitussive agent with the molecular formula C18H29NO3.C6H8O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 67HP51L98R, chemically known as butyric acid, 2-phenyl-, 2-(2-(diethylamino)ethoxy)ethyl ester, citrate but more generally known as butamirate citrate, which bears US NIH Compound Identifier 28891. European Medicines Agency schedules Butamirate citrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00911MIG. Most nations, for tariff and trade purposes, schedule butamirate citrate under HS 29221980 and SITC 51461. As of Q4 2014, BUTAMIRATE CITRATE remains US FDA's Preferred Term for this commodity. SMILES: CCC(C1CCCCC1)C(=O)OCCOCCN(CC)CC.C(C(=O)O)C(CC(=O)O)(C(=O)O)O.

